Screening for malignant pleural mesothelioma and lung cancer in individuals with a history of asbestos exposure

Journal of Thoracic Oncology

Volumn 4, Issue 5, 2009, Pages 620-628

  Roberts, Heidi C ^a,e   Patsios, Demetris A ^a   Paul, Narinder S ^a   De Perrot, Marc ^b   Teel, Warren ^c   Bayanati, Hamid ^a   Shepherd, Frances ^b   Johnston, Michael R ^d  

^a Departments of Medical Imaging   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Ontario Workers Inc   (Canada)

^d QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^e WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

Asbestos; Computed tomography; Mesothelioma; Pleural plaques; Screening

Indexed keywords

ASBESTOS; CARCINOGEN;

ADENOCARCINOMA; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTRAST ENHANCEMENT; DIAPHRAGM; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG BIOPSY; LUNG CALCIFICATION; LUNG CARCINOGENESIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MIXED TUMOR; MULTIDETECTOR COMPUTED TOMOGRAPHY; OCCUPATIONAL EXPOSURE; PERITONEUM MESOTHELIOMA; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SMALL CELL CARCINOMA; SMOKING; SQUAMOUS CELL CARCINOMA; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; INCIDENCE; LUNG TUMOR; MASS SCREENING; MESOTHELIOMA; MIDDLE AGED; PATHOLOGY; PLEURA TUMOR; PROGNOSIS; RADIOGRAPHY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; CARCINOGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; OCCUPATIONAL EXPOSURE; PLEURAL NEOPLASMS; PROGNOSIS; SOLITARY PULMONARY NODULE; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 67651176229     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31819f2e0e     Document Type: Article

References (61)

1. Report of the Royal Commission on Matters of Health and Safety Arising from the use of Asbestos in Ontario (RCO). Chariman: J. Stefan Dupre. Ontario Ministry of the Attorney General, Queen's Printer for Ontario, Toronto, 1984.
2. International Agency for Research on Cancer: Overall evaluation of carcinogenicity. IARC monographs on the evaluation of carcinogenic risk of chemical to humans, supplement 7. Lyon, France: 1987, Pp. 440.
3. Kazan-Allen L. The asbestos war. Int J Occup Environ Health 2003;9: 173-193. (Pubitemid 40292086)
4. Cancer Care Ontario: http://www.cancercare.on.ca/index-cancerfacts- Mesothelioma.htm, Accessed on November 7, 2007.
5. Lilienfeld DE, Mandel JS, Coin P, Schuman LM. Projection of asbestos related diseases in the United States, 1985-2009. I. Cancer. Brit J Ind Med 1988;45:283-291. (Pubitemid 18133435)
6. Baris YL, Simonato L, Artvinli M, et al. Epidemiological and environmental evidence of the health effects of exposure to erionite fibres. Int J Cancer 1987;39:10-17.
7. Comin CE, de Klerk NH, Henderson DW. Malignant Mesothelioma. Ultrastruct Pathol 1997;21:315-320.
8. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 200;44: 565-601.
9. Berry G, de Klerk NH, Reid A, et al. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Environ Med 2004;61:14.
10. Hillerdal G. Pleural plaques. Occurrence, exposure to asbestos, and clinical importance. Uppsala: Acta Universitatis Upsaliensis, 1980:363.
11. Jaervholm B, Sanden A. Pleural plaques and respiratory function. Am J Ind Med 1986;10:419-426.
12. Chailleux E, A Rembeaus, AY de Lajartre, J Delumenau. Pathologie pleurale benigne de l'amiante. Rev Pneumol Clin 1988;44:166-180. (Pubitemid 18276891)
13. Attanoos RL, Gibbs AR. Pathology of malignant mesothelioma. Histopathology 1997;30:403-418.
14. Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005;366:397-408.
15. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;353:1591-1603.
16. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 2006;355:1763-1771. (Pubitemid 44631359)
17. Wang ZJ, Reddy GP, Gotway MB, et al. Malignant Pleural Mesothelioma: evaluation with CT, MR Imaging, and PET. Radiographics 2004; 24:105-119. (Pubitemid 38134597)
18. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99-105.
19. International Early Lung Cancer Action Project, available from www.ielcap.org. Accessed on November 4, 2007.
20. Keith M, Brophy JT. Participatory mapping of occupational hazards and disease among asbestos-exposed workers from a foundry and insulation complex in Canada. Int J Occup Environ Health 2004;10:144-153. (Pubitemid 38780373)
21. Remy-Jardin M, Sobaszek A, Duhamel A, Mastora I, Zanetti C, Remy J. Asbestos-related pleuropulmonary diseases: evaluation with low-dose four-detector row spiral CT. Radiology 2004;233:182-190. (Pubitemid 39280973)
22. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir 1996;9:1932-1942.
23. Pistolesi M, Rusthoven J. Malignant Pleural mesothelioma: update, Current Management, and Newer Therapeutic Strategies. Chest 2004; 126:1318-1329. (Pubitemid 39391267)
24. Burdorf A, Swuste P. An expert system for the evaluation of historical asbestos exposure as diagnostic criterion in asbestos-related diseases. Ann Occup Hyg 1999;43:57-66. (Pubitemid 29073314)
25. Lanphear BP, Buncher CR. Latent period of malignant mesothelioma of occupational origin. J Occup Med 1992;7:718-722.
26. Chapman SJ, Cookson WOC, Musk AW, et al. Benign pleural diseases. Curr Opin Pulm Med 2003;9:266-271.
27. Bianchi C, Brollo A, Ramani L, Zuch C. Pleural plaques as risk indicators for malignant pleural mesothelioma: a necropsy-based study. Am J Ind Med 1997;32:445-449. (Pubitemid 27419245)
28. Hillerdal G. Pleural plaques and risk for bronchial carcinoma and mesothelioma. Chest 1994;105:144-150.
29. Bianchi C, Brollo A, Ramani L, Berte R. Exposure to asbestos in Monfalcone, Italy. A necropsy based study. In Riboli E, Delendi M, (Eds), Autopsy in Epidemiology and Medical Research. Lyon: IARC, 1991. Pp. 127-140.
30. Weber MA, Bock M, Plathow C, et al. Asbestos-related pleural disease: value of dedicated magnetic resonance imaging techniques. Invest Radiol 2004;39:554-564. (Pubitemid 39096773)
31. Peacock C, Copley SJ, Hansell DM. Asbestos-related benign pleural disease. Clin Radiol 2000;55:422-432. (Pubitemid 32054548)
32. Copley SJ, Wells AU, Rubens MB, et al. Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 2001;220:237-243.
33. Oliver LC, Eisen EA, Greene R, Sprince NL. Asbestos-related pleural plaques and lung function. Am J Ind Med 1988;14:649-656. (Pubitemid 19000076)
34. Ohlson CG, Rydman T, Sundell L, Bodin L, Hogstedt C. Decreased lung function in long-term asbestos cement workers: a cross-sectional study. Am J Ind Med 1984;5:359-366. (Pubitemid 14128646)
35. Guidotti TL, Miller A, Christiani D, et al. Nonmalignant Asbestosrelated disease: diagnosis and early management. Clin Pulm Med 2007; 14:82-92. (Pubitemid 46673695)
36. Gibson GJ. Disease of the pleura and chest wall. In Gibson GJ, (Ed). Clinical tests of respiratory function, 2nd Ed. London, England: Chapman & Hall Medical, 1996. Pp. 256-266.
37. Withers BF, Ducatman AM, Yang WN. Roentgenographic evidence for predominant left sided location of unilateral pleural plaques. Chest 1989;95:1262-1264.
38. Fasola G, Belvedere O, Aita M, et al. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestosexposed population: Baseline results of a prospective, nonrandomized feasibility trial-an Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002). Oncologist 2007;12:1215-1224. (Pubitemid 350106352)
39. Creaney J, Yeoman D, Naumoff LK, et al. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 2007;62:569-576. (Pubitemid 47056881)
40. Rockoff SD, Kagan E, Schwartz A, Kriebel D, Hix W, Rohatgi P. Visceral pleural thickening in asbestos exposure: the occurrence and implications of thickened interlobar fissures. J Thorac Imag 1987;2:58-66.
41. Kaira K, Dobashi K, Yanagitani N, et al. Rapid Growth of Malignant Pleural Mesothelioma. J Thorac Oncol 2007;2:966-967. (Pubitemid 47511602)
42. Lulenski GC, Pitarre R, Neville WF. Rapid growth of a pleural mesothelioma. Chest 1971;59:230-232.
43. Lie JT. Sudden death as the initial manifestation of diffuse pleural mesothelioma. Chest 1989;95:682-684.
44. Henderson DW, Rodelsperger K, Woitowitz HJ, Leigh J. After Helsinki: a multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published 1997-2004. Pathology 2004;36:517-550. (Pubitemid 40091465)
45. Hammond EC, Selikoff IJ, Seidman H. Asbestos exposure, cigarette smoking and death rates. Ann N Y Acad Sci 1979;330:473-490. (Pubitemid 11223577)
46. Vainio H, Boffetta P. Mechanisms of the combined effect of asbestos and smoking in the etiology of lung cancer. Scand J Work Environ Health 1994;20:235-242. (Pubitemid 24291305)
47. Karjalainen A, Pukkala E, Kauppinen T, Partanen T. Incidence of cancer among Finnish patients. Cancer Causes Control 1999;10:51-57.
48. Armstrong BK, Musk AW, Baker JE, et al. Epidemiology of mesotheliom in Western Australia. Med J Aust 1984;141:86-88.
49. Copley SJ, Lee YC, Hansell DM, et al. asbestos-induced and smokingrelated disease: apportioning pulmonary function deficit by using thinsection CT. Radiology 2007;242:258-266.
50. Vierikko T, JärvenpääR, Autti T, et al. Chest CT screening of asbestosexposed workers: lung lesions and incidental findings. Eur Respir J 2007;29:78-84. (Pubitemid 46092001)
51. Das M, Muehlenbruch G, Mahnken AH, et al. Asbestos Surveillance Program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high-risk individuals using low-dose multidetector- row CT. Eur Radiol 2007;17:1193-1199. (Pubitemid 46691948)
52. Roberts HC, Patsios D, Paul NS, et al. Lung cancer screening with low-dose computed tomography: Canadian experience. Can Ass Radiol J 2007;58:225-235. (Pubitemid 350021946)
53. Tiitola M, Kivisaari L, Huuskonen MS, et al. Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 2002;35:17-22.
54. Robinson BWS. Soluble mesothelin-related protein-a sensitive new marker for mesothelioma. Am J Oncol Rev 2004;3:230-233.
55. Chaisaowong K, Jaeger P, Vogel S, Knepper A, Kraus T, Aach T. Computer-assisted diagnosis for early stage pleural mesothelioma: automated extraction of pleura to detect pleural thickenings from thoracic CT images. Methods Inf Med 2007;46:324-331. (Pubitemid 46807205)
56. Boraschi P, Neri MD, Braccini G, et al. Magnetic resonance appearance of asbestos-related benign and malignant pleural disease. Scan J Work Envorn Health 1999;25:18-23. (Pubitemid 29129371)
57. Falaschi F, Battolla L, Mascalchi M, et al. Usefulness of MR signal intensity in distinguishing benign from malignant pleural disease. AJR Am J Roentgenol 1996;166:936-968. (Pubitemid 26102085)
58. Truong MT, Marom EM, Erasmus JJ. Preoperative evaluation of patients with malignant pleural mesothelioma: role of integrated CT-PET imaging. J Thorac Imaging 200;21:146-153.
59. Flores FM, Zakowki M, Venkatranam E, et al. Prognostic Factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thor Oncol 2007;2:957-965.
60. Sugarbaker DJ, Jaklitsch MR, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004;128:138-146. (Pubitemid 38881208)
61. de Perrot M, Feld R, Anraku M, et al. Impact of induction chemotherapy and adjuvant radiation therapy on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma. J Clini Oncol 2007; 25(18S):436s (abstract 7708).